Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA)

Metabolism: Clinical and Experimental

Volumn 65, Issue 3, 2016, Pages 64-72

  Bancks, Michael P ^a   Bielinski, Suzette J ^b   Decker, Paul A ^b   Hanson, Naomi Q ^c   Larson, Nicholas B ^b   Sicotte, Hugues ^b   Wassel, Christina L ^d   Pankow, James S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

Diabetes mellitus; Ethnicity; Hepatocyte growth factor; Incidence; Longitudinal

Indexed keywords

BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HGF PROTEIN, HUMAN; SCATTER FACTOR;

AGED; ATHEROSCLEROSIS; BLOOD; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; ETHNIC GROUP; FEMALE; HUMAN; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR; SEXUAL DEVELOPMENT; SOCIOECONOMICS; UNITED STATES;

AGED; ATHEROSCLEROSIS; BIOMARKERS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84958225691     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.10.023     Document Type: Article

References (22)

1. R. Zarnegar, and G.K. Michalopoulos The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis J Cell Biol 129 1995 1177 1180
2. H. Funakoshi, and T. Nakamura Hepatocyte growth factor: from diagnosis to clinical applications Clin Chim Acta 327 2003 1 23
3. M. Otsuka, H. Adachi, D.R. Jacobs Jr., Y. Hirai, M. Enomoto, A. Fukami, and et al. Serum hepatocyte growth factor and cancer mortality in an apparently healthy Japanese population J Epidemiol 22 2012 395 401
4. N. Lamblin, S. Susen, J. Dagorn, F. Mouquet, B. Jude, E. Van Belle, and et al. Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure Am Heart J 150 2005 137 143
5. S.N. Rajpathak, T. Wang, S. Wassertheil-Smoller, H.D. Strickler, R.C. Kaplan, A.P. McGinn, and et al. Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health Initiative Stroke 41 2010 857 862
6. G. Perdomo, M.A. Martinez-Brocca, B.A. Bhatt, N.F. Brown, R.M. O'Doherty, and A. Garcia-Ocana Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells J Biol Chem 283 2008 13700 13706
7. A. Fafalios, J. Ma, X. Tan, J. Stoops, J. Luo, M.C. Defrances, and et al. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism Nat Med 17 2011 1577 1584
8. A. Hiratsuka, H. Adachi, Y. Fujiura, S. Yamagishi, Y. Hirai, M. Enomoto, and et al. Strong association between serum hepatocyte growth factor and metabolic syndrome J Clin Endocrinol Metab 90 2005 2927 2931
9. S.N. Rajpathak, S. Wassertheil-Smoller, J. Crandall, S. Liu, and G.Y. Ho Hepatocyte growth factor and clinical diabetes in postmenopausal women Diabetes Care 33 2010 2013 2015
10. B. Kulseng, M. Borset, T. Espevik, and A. Sundan Elevated hepatocyte growth factor in sera from patients with insulin-dependent diabetes mellitus Acta Diabetol 35 1998 77 80
11. J. Rehman, R.V. Considine, J.E. Bovenkerk, J. Li, C.A. Slavens, R.M. Jones, and et al. Obesity is associated with increased levels of circulating hepatocyte growth factor J Am Coll Cardiol 41 2003 1408 1413
12. C. Nowak, J. Sundstrom, S. Gustafsson, V. Giedraitis, L. Lind, E. Ingelsson, and et al. Protein biomarkers for insulin resistance and type 2 diabetes risk in two large community cohorts Diabetes 2015 Sep 29 [Epub ahead of print]
13. L.N. Bell, J.L. Ward, M. Degawa-Yamauchi, J.E. Bovenkerk, R. Jones, B.M. Cacucci, and et al. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity Am J Physiol Endocrinol Metab 291 2006 E843 E848
14. J. Swierczynski, J. Korczynska, E. Goyke, K. Adrych, S. Raczynska, and Z. Sledzinski Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty Obes Surg 15 2005 803 808
15. E. Tsukagawa, H. Adachi, Y. Hirai, M. Enomoto, A. Fukami, K. Ogata, and et al. Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10-year prospective study Clin Endocrinol (Oxf) 79 2013 43 48
16. D.E. Bild, D.A. Bluemke, G.L. Burke, R. Detrano, A.V. Diez Roux, A.R. Folsom, and et al. Multi-ethnic study of atherosclerosis: objectives and design Am J Epidemiol 156 2002 871 881
17. B. Psaty, M. Lee, P. Savage, G. Rutan, P. German, and M. Lyles Assessing the use of medications in the elderly: Methods and initial experience in the cardiovascular health study J Clin Epidemiol 45 1992 683 692
18. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
19. M.A. Hernan, S. Hernandez-Diaz, M.M. Werler, and A.A. Mitchell Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology Am J Epidemiol 155 2002 176 184
20. R.P. Hertz, A.N. Unger, and C.M. Ferrario Diabetes, hypertension, and dyslipidemia in Mexican Americans and non-Hispanic whites Am J Prev Med 30 2006 103 110
21. J.W. Lee, F.L. Brancati, and H.C. Yeh Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008 Diabetes Care 34 2011 353 357
22. S.-A. Lee, A. Kallianpur, Y.-B. Xiang, W. Wen, Q. Cai, D. Liu, and et al. Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies Cancer Epidemiol Biomarkers Prev 16 2007 2464 2470